BMS to pull Tequin antibiotic from the shelves

May 1, 2006
The Washington Post reports that Tequin is being withdrawn from the market, due to blood sugar complications that it can cause.
The Washington Post reports that Tequin is being withdrawn from the market, due to blood sugar complications that it can cause.
About the Author

pharmamanufacturing | pharmamanufacturing